Arkolith/Insider Trading/AQST/Form 4

Krop Julie

DirectorAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$125K
Net Open-Market Flow
-$125K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)25K$0.71$18K25K
Jun 23, 2026Sell(S)25K$5.02$125K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)25K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-007677) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML